Skip to main content
Top
Published in: Malaria Journal 1/2012

Open Access 01-12-2012 | Research

Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border

Authors: Fang Huang, Linhua Tang, Henglin Yang, Shuisen Zhou, Xiaodong Sun, Hui Liu

Published in: Malaria Journal | Issue 1/2012

Login to get access

Abstract

Background

The aim of this study was to evaluate the clinical outcome after seven-day artesunate monotherapy for uncomplicated Plasmodium falciparum malaria in Yingjiang County along the China-Myanmar border and investigate genetic polymorphisms in the P. falciparum chloroquine-resistance transporter (pfcrt), multidrug resistance 1 (pfmdr1), dihydrofolate reductase (pfdhfr), dihydropteroate synthase (pfdhps) and ATPase (pfatp6) genes.

Methods

Patients ≥ one year of age with fever (axillary temperature ≥37.5°C) or history of fever and P. falciparum mono-infection were included. Patients received anti-malarial treatment with artesunate (total dose of 16 mg/kg over seven days) by directly observed therapy. After a 28-day follow-up, treatment efficacy and effectiveness were assessed based on clinical and parasitological outcomes. Treatment failure was defined as recrudescence of the original parasite and distinguished with new infection confirmed by PCR. Analysis of gene mutation and amplification were performed by nested polymerase chain reaction.

Results

Sixty-five patients were enrolled; 10 withdrew from the study, and six were lost to follow-up. All but two patients demonstrated adequate clinical and parasitological response; 12 had detectable parasitaemia on day 3. These two patients were confirmed to be new infection by PCR. The efficacy of artesunate was 95.9%. The pfcrt mutation in codon 76 was found in all isolates (100%), and mutations in codons 71 and 72 were found in 4.8% of parasite isolates. No mutation of pfmdr1 (codons 86 or 1246) was found. Among all samples, 5.1% were wild type for pfdhfr, whereas the other samples had mutations in four codons (51, 59, 108 and 164), and mutations in pfdhps (codons 436, 437, 540 and 581) were found in all isolates. No samples had mutations in pfatp6 codons 623 or 769, but two new mutations (N683K and R756K) were found in 4.6% and 9.2% of parasite isolates, respectively.

Conclusion

Plasmodium falciparum infection was associated with slow parasite clearance and suspected artemisinin resistance at the China-Myanmar border area. The prevalence of pfcrt 76 T and markers for SP resistance are still high. It should be strengthened further on parasite clearance time or clearance half life to confirm the resistance status, and molecular epidemiology should provide complementary information to assess the appropriateness of current policies based on artemisinin derivatives.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: WHO Malaria report. 2009, Geneva: World Health Organization WHO: WHO Malaria report. 2009, Geneva: World Health Organization
2.
go back to reference Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-67. 10.1056/NEJMoa0808859.PubMedCentralCrossRefPubMed Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-67. 10.1056/NEJMoa0808859.PubMedCentralCrossRefPubMed
3.
go back to reference WHO: Global report on antimalarial drug efficacy and drug resistance: 2000–2010. 2010, Geneva: World Health Organization WHO: Global report on antimalarial drug efficacy and drug resistance: 2000–2010. 2010, Geneva: World Health Organization
4.
go back to reference WHO: World malaria report. 2010, Geneva: World Health Organization WHO: World malaria report. 2010, Geneva: World Health Organization
5.
go back to reference Zhou SS, Wang Y, Li Y: Malaria situation in the People’s Republic of China in 2010. Chin J Parasitol Parasit Dis. 2011, 29: 401-403. Zhou SS, Wang Y, Li Y: Malaria situation in the People’s Republic of China in 2010. Chin J Parasitol Parasit Dis. 2011, 29: 401-403.
6.
go back to reference WHO: Guidelines for the treatment of malaria. 2010, World Health Organization WHO: Guidelines for the treatment of malaria. 2010, World Health Organization
8.
go back to reference Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D: A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001, 344: 257-263. 10.1056/NEJM200101253440403.CrossRefPubMed Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D: A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001, 344: 257-263. 10.1056/NEJM200101253440403.CrossRefPubMed
9.
go back to reference Ursing J, Kofoed PE, Rodrigues A, Rombo L, Gil JP: Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. Am J Trop Med Hyg. 2007, 76: 844-848.PubMed Ursing J, Kofoed PE, Rodrigues A, Rombo L, Gil JP: Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. Am J Trop Med Hyg. 2007, 76: 844-848.PubMed
10.
go back to reference Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P: A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009, 8: 89-10.1186/1475-2875-8-89.PubMedCentralCrossRefPubMed Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P: A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009, 8: 89-10.1186/1475-2875-8-89.PubMedCentralCrossRefPubMed
11.
go back to reference Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D: High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J Infect Dis. 2001, 183: 1535-1538. 10.1086/320195.CrossRefPubMed Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D: High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J Infect Dis. 2001, 183: 1535-1538. 10.1086/320195.CrossRefPubMed
12.
go back to reference Basco LK, Ringwald P: Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Am J Trop Med Hyg. 2000, 62: 271-276.PubMed Basco LK, Ringwald P: Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Am J Trop Med Hyg. 2000, 62: 271-276.PubMed
14.
go back to reference Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV: Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002, 185: 380-388. 10.1086/338566.CrossRefPubMed Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV: Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002, 185: 380-388. 10.1086/338566.CrossRefPubMed
15.
go back to reference Lynch C, Pearce R, Pota H, Cox J, Abeku TA, Rwakimari J, Naidoo I, Tibenderana J, Roper C: Emergence of a dhfr mutation conferring highlevel drug resistance in Plasmodium falciparum populations from southwest Uganda. J Infect Dis. 2008, 197: 1598-1604. 10.1086/587845.CrossRefPubMed Lynch C, Pearce R, Pota H, Cox J, Abeku TA, Rwakimari J, Naidoo I, Tibenderana J, Roper C: Emergence of a dhfr mutation conferring highlevel drug resistance in Plasmodium falciparum populations from southwest Uganda. J Infect Dis. 2008, 197: 1598-1604. 10.1086/587845.CrossRefPubMed
16.
go back to reference Imwong M, Pukrittayakamee S, Pongtavornpinyo W, Nakeesathit S, Nair S, Newton P, Nosten F, Anderson TJ, Dondorp A, Day NP, White NJ: Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar. Antimicrob Agents Chemother. 2008, 52: 2657-2659. 10.1128/AAC.01459-07.PubMedCentralCrossRefPubMed Imwong M, Pukrittayakamee S, Pongtavornpinyo W, Nakeesathit S, Nair S, Newton P, Nosten F, Anderson TJ, Dondorp A, Day NP, White NJ: Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar. Antimicrob Agents Chemother. 2008, 52: 2657-2659. 10.1128/AAC.01459-07.PubMedCentralCrossRefPubMed
17.
go back to reference Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S: A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol. 2005, 12 (7): 628-9. 10.1038/nsmb947.CrossRefPubMed Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S: A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol. 2005, 12 (7): 628-9. 10.1038/nsmb947.CrossRefPubMed
20.
go back to reference Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C: Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother. 2003, 47: 1347-1354. 10.1128/AAC.47.4.1347-1354.2003.PubMedCentralCrossRefPubMed Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C: Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother. 2003, 47: 1347-1354. 10.1128/AAC.47.4.1347-1354.2003.PubMedCentralCrossRefPubMed
21.
22.
go back to reference Sidhu AB, Verdier-Pinard D, Fidock DA: Chloroquine resistance in Plasomodium falciparum malaria parasites conferred by pfcrt mutations. Science. 2002, 298: 210-213. 10.1126/science.1074045.PubMedCentralCrossRefPubMed Sidhu AB, Verdier-Pinard D, Fidock DA: Chloroquine resistance in Plasomodium falciparum malaria parasites conferred by pfcrt mutations. Science. 2002, 298: 210-213. 10.1126/science.1074045.PubMedCentralCrossRefPubMed
23.
go back to reference Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC: The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol. 2000, 108: 13-23. 10.1016/S0166-6851(00)00201-2.CrossRefPubMed Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC: The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol. 2000, 108: 13-23. 10.1016/S0166-6851(00)00201-2.CrossRefPubMed
24.
go back to reference Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qiu CP, Cai XZ, Ling CF, Liang AH, Tang Y: Alteration in resistance of Plasmodium falciparum to chloroquine after cessation of chloroquine medication for twelve years. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1992, 10: 241-244.PubMed Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qiu CP, Cai XZ, Ling CF, Liang AH, Tang Y: Alteration in resistance of Plasmodium falciparum to chloroquine after cessation of chloroquine medication for twelve years. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1992, 10: 241-244.PubMed
25.
go back to reference Guan YY, Tang LH, Hu L, Feng XP, Liu DQ: The point mutations in Pfcrt and Pfmdr1 genes in Plasmodium falciparum isolated from Hainan Province. Chin J Parasitol Parasit Dis. 2005, 23: 135-139. Guan YY, Tang LH, Hu L, Feng XP, Liu DQ: The point mutations in Pfcrt and Pfmdr1 genes in Plasmodium falciparum isolated from Hainan Province. Chin J Parasitol Parasit Dis. 2005, 23: 135-139.
26.
go back to reference Yang Z, Zhang Z, Sun X, Wan W, Cui L: Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province China. Trop Med Int Health. 2007, 12: 1051-60. 10.1111/j.1365-3156.2007.01882.x.CrossRefPubMed Yang Z, Zhang Z, Sun X, Wan W, Cui L: Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province China. Trop Med Int Health. 2007, 12: 1051-60. 10.1111/j.1365-3156.2007.01882.x.CrossRefPubMed
27.
go back to reference Zhang GQ, Guan YY, Zheng B, Wu S, Tang LH: Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China. Trop Med Int Health. 2009, 14: 1266-71. 10.1111/j.1365-3156.2009.02342.x.CrossRefPubMed Zhang GQ, Guan YY, Zheng B, Wu S, Tang LH: Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China. Trop Med Int Health. 2009, 14: 1266-71. 10.1111/j.1365-3156.2009.02342.x.CrossRefPubMed
28.
go back to reference Zhang SX: Efficiency of Pyrimethamine combined with primaquine for radical treatment of P.vivax. Xinyang Medical and Health compilation. 1965, 2: 32-unpublished data Zhang SX: Efficiency of Pyrimethamine combined with primaquine for radical treatment of P.vivax. Xinyang Medical and Health compilation. 1965, 2: 32-unpublished data
29.
go back to reference Wang RZ: Efficiency of pyrimethamine salt for P.vivax prophylaxis. Railway Medicine. 1981, 4: 246-247. Wang RZ: Efficiency of pyrimethamine salt for P.vivax prophylaxis. Railway Medicine. 1981, 4: 246-247.
30.
go back to reference Ejov MN, Tun T, Aung S, Sein K: Response of falciparum malaria to different antimalarials in Myanmar. Bull World Health Organ. 1999, 77: 244-249.PubMedCentralPubMed Ejov MN, Tun T, Aung S, Sein K: Response of falciparum malaria to different antimalarials in Myanmar. Bull World Health Organ. 1999, 77: 244-249.PubMedCentralPubMed
31.
go back to reference Triglia T, Menting JG, Wilson C, Cowman AF: Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci. 1997, 94: 13944-13949. 10.1073/pnas.94.25.13944.PubMedCentralCrossRefPubMed Triglia T, Menting JG, Wilson C, Cowman AF: Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci. 1997, 94: 13944-13949. 10.1073/pnas.94.25.13944.PubMedCentralCrossRefPubMed
32.
go back to reference Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O: Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet. 2005, 366: 1960-1963. 10.1016/S0140-6736(05)67787-2.CrossRefPubMed Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O: Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet. 2005, 366: 1960-1963. 10.1016/S0140-6736(05)67787-2.CrossRefPubMed
33.
go back to reference Bertaux L, le Quang H, Sinou V, Thanh NX, Parzy D: New PfATP6 mutations found in Plasmodium falciparum isolates from Vietnam. Antimicrob Agents Chemother. 2009, 53: 4570-4571. 10.1128/AAC.00684-09.PubMedCentralCrossRefPubMed Bertaux L, le Quang H, Sinou V, Thanh NX, Parzy D: New PfATP6 mutations found in Plasmodium falciparum isolates from Vietnam. Antimicrob Agents Chemother. 2009, 53: 4570-4571. 10.1128/AAC.00684-09.PubMedCentralCrossRefPubMed
34.
go back to reference Dahlström S, Veiga MI, Ferreira P, Mårtensson A, Kaneko A, Andersson B, Björkman A, Gil JP: Diversity of the sarco/endoplasmic reticulum Ca2 + −ATPase orthologue of Plasmodium falciparum (PfATP6). Infect Genet Evol. 2008, 8: 340-345. 10.1016/j.meegid.2008.02.002.CrossRefPubMed Dahlström S, Veiga MI, Ferreira P, Mårtensson A, Kaneko A, Andersson B, Björkman A, Gil JP: Diversity of the sarco/endoplasmic reticulum Ca2 + −ATPase orthologue of Plasmodium falciparum (PfATP6). Infect Genet Evol. 2008, 8: 340-345. 10.1016/j.meegid.2008.02.002.CrossRefPubMed
35.
go back to reference Ibrahim ML, Khim N, Adam HH, Ariey F, Duchemin JB: Polymorphism of PfATPase in Niger: detection of three new point mutations. Malar J. 2009, 8: 28-10.1186/1475-2875-8-28.PubMedCentralCrossRefPubMed Ibrahim ML, Khim N, Adam HH, Ariey F, Duchemin JB: Polymorphism of PfATPase in Niger: detection of three new point mutations. Malar J. 2009, 8: 28-10.1186/1475-2875-8-28.PubMedCentralCrossRefPubMed
36.
go back to reference Menegon M, Sannella AR, Majori G, Severini C: Detection of novel point mutations in the Plasmodium falciparum ATPase6 candidate gene for resistance to artemisinins. Parasitol Int. 2008, 57: 233-235. 10.1016/j.parint.2007.12.004.CrossRefPubMed Menegon M, Sannella AR, Majori G, Severini C: Detection of novel point mutations in the Plasmodium falciparum ATPase6 candidate gene for resistance to artemisinins. Parasitol Int. 2008, 57: 233-235. 10.1016/j.parint.2007.12.004.CrossRefPubMed
37.
go back to reference Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F: Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012, 379: 1960-1966. 10.1016/S0140-6736(12)60484-X.PubMedCentralCrossRefPubMed Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F: Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012, 379: 1960-1966. 10.1016/S0140-6736(12)60484-X.PubMedCentralCrossRefPubMed
Metadata
Title
Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border
Authors
Fang Huang
Linhua Tang
Henglin Yang
Shuisen Zhou
Xiaodong Sun
Hui Liu
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-278

Other articles of this Issue 1/2012

Malaria Journal 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.